Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice

Journal of Neural Transmission

Volumn 115, Issue 11, 2008, Pages 1501-1511

  Naderi, Nima ^a   Aziz Ahari, Farzad ^a   Shafaghi, Bijan ^a   Hosseini Najarkolaei, Azadeh ^a   Motamedi, Fereshteh ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cannabinoids; Diazepam; Electroshock induced seizure test; Interaction; Mice; Seizure

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; DIAZEPAM; N (4 HYDROXYPHENYL)ARACHIDONAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ELECTRIC SHOCK; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SEIZURE;

AMIDOHYDROLASES; ANIMALS; ANTICONVULSANTS; ARACHIDONIC ACIDS; BENZAMIDES; BENZOXAZINES; CANNABINOIDS; CARBAMATES; DIAZEPAM; DRUG INTERACTIONS; ELECTROSHOCK; ENDOCANNABINOIDS; ENZYME INHIBITORS; MALE; MICE; MORPHOLINES; NAPHTHALENES; POSTURAL BALANCE; RECEPTOR, CANNABINOID, CB1; SEIZURES;

EID: 55349089895     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-008-0076-x     Document Type: Article

References (68)

1. ME Abood G Rizvi N Sallapudi SD McAllister 2001 Activation of the CB1 cannabinoid receptor protects cultured mouse spinal neurons against excitotoxicity Neurosci Lett 309 197 201
2. IB Adams BR Martin 1996 Cannabis: pharmacology and toxicology in animals and humans Addiction 91 1585 1614
3. BE Alger 2002 Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids Prog Neurobiol 68 247 286
4. BE Alger 2004 Endocannabinoids and their implications for epilepsy Epilepsy Curr 4 169 173
5. SC Azad M Eder G Marsicano B Lutz W Zieglgansberger G Rammes 2003 Activation of the cannabinoid receptor type 1 decreases glutamatergic and GABAergic synaptic transmission in the lateral amygdala of the mouse Learn Mem 10 116 128
6. D Baker G Pryce JL Croxford P Brown RG Pertwee A Makriyannis A Khanolkar L Layward F Fezza T Bisogno V Di Marzo 2001 Endocannabinoids control spasticity in a multiple sclerosis model Faseb J 15 300 302
7. M Beltramo N Stella A Calignano SY Lin A Makriyannis D Piomelli 1997 Functional role of high-affinity anandamide transport, as revealed by selective inhibition Science 277 1094 1097
8. M Ben Amar 2006 Cannabinoids in medicine: a review of their therapeutic potential J Ethnopharmacol 105 1 25
9. RE Blair LS Deshpande S Sombati KW Falenski BR Martin RJ DeLorenzo 2006 Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus J Pharmacol Exp Ther 317 1072 1078
10. TR Browne GL Holmes 2001 Epilepsy N Engl J Med 344 1145 1151
11. K Chen TZ Baram I Soltesz 1999 Febrile seizures in the developing brain result in persistent modification of neuronal excitability in limbic circuits Nat Med 5 888 894
12. K Chen A Ratzliff L Hilgenberg A Gulyas TF Freund M Smith TP Dinh D Piomelli K Mackie I Soltesz 2003 Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures Neuron 39 599 611
13. AB Clement EG Hawkins AH Lichtman BF Cravatt 2003 Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase J Neurosci 23 3916 3923
14. P Consroe A Martin V Singh 1981 Antiepileptic potential of cannabidiol analogs J Clin Pharmacol 21 428S 436S
15. P Consroe MA Benedito JR Leite EA Carlini R Mechoulam 1982 Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice Eur J Pharmacol 83 293 298
16. JM Cunha EA Carlini AE Pereira OL Ramos C Pimentel R Gagliardi WL Sanvito N Lander R Mechoulam 1980 Chronic administration of cannabidiol to healthy volunteers and epileptic patients Pharmacology 21 175 185
17. SJ Czuczwar KK Borowicz 2002 Polytherapy in epilepsy: the experimental evidence Epilepsy Res 52 15 23
18. CL Deckers SJ Czuczwar YA Hekster A Keyser H Kubova H Meinardi PN Patsalos WO Renier CM Van Rijn 2000 Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed Epilepsia 41 1364 1374
19. LS Deshpande S Sombati RE Blair DS Carter BR Martin RJ DeLorenzo 2007 Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy Neurosci Lett 411 11 16
20. WA Devane L Hanus A Breuer RG Pertwee LA Stevenson G Griffin D Gibson A Mandelbaum A Etinger R Mechoulam 1992 Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1946 1949
21. V Di Marzo M Bifulco L De Petrocellis 2004 The endocannabinoid system and its therapeutic exploitation Nat Rev Drug Discov 3 771 784
22. D Fegley S Gaetani A Duranti A Tontini M Mor G Tarzia D Piomelli 2005 Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3′-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation J Pharmacol Exp Ther 313 352 358
23. TF Freund I Katona D Piomelli 2003 Role of endogenous cannabinoids in synaptic signaling Physiol Rev 83 1017 1066
24. C Gennings WH Carter Jr ED Campbell JG Staniswalis TJ Martin BR Martin KL White Jr 1990 Isobolographic characterization of drug interactions incorporating biological variability J Pharmacol Exp Ther 252 208 217
25. GL Gerdeman DM Lovinger 2003 Emerging roles for endocannabinoids in long-term synaptic plasticity Br J Pharmacol 140 781 789
26. GL Gerdeman J Ronesi DM Lovinger 2002 Postsynaptic endocannabinoid release is critical to long-term depression in the striatum Nat Neurosci 5 446 451
27. S Gonzalez J Romero R de Miguel I Lastres-Becker MA Villanua A Makriyannis JA Ramos JJ Fernandez-Ruiz 1999 Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide Life Sci 65 327 336
28. E Gordon O Devinsky 2001 Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy Epilepsia 42 1266 1272
29. M Herkenham AB Lynn MR Johnson LS Melvin BR de Costa KC Rice 1991 Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study J Neurosci 11 563 583
30. AC Howlett 1995 Pharmacology of cannabinoid receptors Annu Rev Pharmacol Toxicol 35 607 634
31. AC Howlett F Barth TI Bonner G Cabral P Casellas WA Devane CC Felder M Herkenham K Mackie BR Martin R Mechoulam RG Pertwee 2002 International union of pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol Rev 54 161 202
32. AC Howlett CS Breivogel SR Childers SA Deadwyler RE Hampson LJ Porrino 2004 Cannabinoid physiology and pharmacology: 30 years of progress Neuropharmacology 47 Suppl 1 345 358
33. DM Jonker RA Voskuyl M Danhof 2007 Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments? Epilepsia 48 412 434
34. R Kalviainen 2001 Monotherapy trial design: conversion versus de novo Epilepsy Res 45 75 78 Discussion 79-80
35. R Karler W Cely SA Turkanis 1973 The anticonvulsant activity of cannabidiol and cannabinol Life Sci 13 1527 1531
36. R Karler W Cely SA Turkanis 1974 Anticonvulsant properties of delta 9-tetrahydrocannabinol and other cannabinoids Life Sci 15 931 947
37. FU Knudsen 2000 Febrile seizures: treatment and prognosis Epilepsia 41 2 9
38. JT Litchfield Jr F Wilcoxon 1949 A simplified method of evaluating dose-effect experiments J Pharmacol Exp Ther 96 99 113
39. W Loscher 2002 Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy Epilepsy Res 50 105 123
40. W Loscher 2002 Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy CNS Drugs 16 669 694
41. W Loscher 2002 Current status and future directions in the pharmacotherapy of epilepsy Trends Pharmacol Sci 23 113 118
42. N Lozovaya N Yatsenko A Beketov T Tsintsadze N Burnashev 2005 Glycine receptors in CNS neurons as a target for nonretrograde action of cannabinoids J Neurosci 25 7499 7506
43. JJ Luszczki P Czuczwar A Cioczek-Czuczwar SJ Czuczwar 2006 Arachidonyl-2′-chloroethylamide, a highly selective cannabinoid CB1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model Eur J Pharmacol 547 65 74
44. B Lutz 2002 Molecular biology of cannabinoid receptors Prostaglandins Leukot Essent Fatty Acids 66 123 142
45. B Lutz 2004 On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures Biochem Pharmacol 68 1691 1698
46. G Marsicano B Lutz 1999 Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain Eur J Neurosci 11 4213 4225
47. G Marsicano S Goodenough K Monory H Hermann M Eder A Cannich SC Azad MG Cascio SO Gutierrez M van der Stelt ML Lopez-Rodriguez E Casanova G Schutz W Zieglgansberger V Di Marzo C Behl B Lutz 2003 CB1 cannabinoid receptors and on-demand defense against excitotoxicity Science 302 84 88
48. LA Matsuda SJ Lolait MJ Brownstein AC Young TI Bonner 1990 Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 561 564
49. JA McCaughran Jr ME Corcoran JA Wada 1974 Anticonvulsant activity of delta-8- and delta-9-tetrahydrocannabinol in rats Pharmacol Biochem Behav 2 227 233
50. MK McKinney BF Cravatt 2005 Structure and function of fatty acid amide hydrolase Annu Rev Biochem 74 411 432
51. R Mechoulam Y Gaoni 1965 A total synthesis of Dl-delta-1- tetrahydrocannabinol, the active constituent of hashish J Am Chem Soc 87 3273 3275
52. R Mechoulam L Hanus 2002 Cannabidiol: an overview of some chemical and pharmacological aspects. Part I: chemical aspects Chem Phys Lipids 121 35 43
53. E Perucca 2004 NICE guidance on newer drugs for epilepsy in adults BMJ 328 1273 1274
54. D Piomelli 2003 The molecular logic of endocannabinoid signalling Nat Rev Neurosci 4 873 884
55. AM Ray CD Benham JC Roberts CH Gill C Lanneau DP Gitterman M Harries JB Davis CH Davies 2003 Capsazepine protects against neuronal injury caused by oxygen glucose deprivation by inhibiting I(h) J Neurosci 23 10146 10153
56. D Robbe M Kopf A Remaury J Bockaert OJ Manzoni 2002 Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens Proc Natl Acad Sci USA 99 8384 8388
57. NP Rosman T Colton J Labazzo PL Gilbert NB Gardella EM Kaye C Van Bennekom MR Winter 1993 A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures N Engl J Med 329 79 84
58. JW Sander 1993 Some aspects of prognosis in the epilepsies: a review Epilepsia 34 1007 1016
59. PF Smith 2005 Cannabinoids as potential anti-epileptic drugs Curr Opin Investig Drugs 6 680 685
60. N Stella P Schweitzer D Piomelli 1997 A second endogenous cannabinoid that modulates long-term potentiation Nature 388 773 778
61. DM Treiman 1989 Pharmacokinetics and clinical use of benzodiazepines in the management of status epilepticus Epilepsia 30 Suppl 2 S4 S10
62. WB Veldhuis M van der Stelt MW Wadman G van Zadelhoff M Maccarrone F Fezza GA Veldink JF Vliegenthart PR Bar K Nicolay V Di Marzo 2003 Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases J Neurosci 23 4127 4133
63. MJ Wallace JL Wiley BR Martin RJ DeLorenzo 2001 Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects Eur J Pharmacol 428 51 57
64. MJ Wallace BR Martin RJ DeLorenzo 2002 Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity Eur J Pharmacol 452 295 301
65. MJ Wallace RE Blair KW Falenski BR Martin RJ DeLorenzo 2003 The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy J Pharmacol Exp Ther 307 129 137
66. RI Wilson RA Nicoll 2002 Endocannabinoid signaling in the brain Science 296 678 682
67. LA Woodbury VD Davenport 1952 Design and use of a new electroshock seizure apparatus, and analysis of factors altering seizure threshold and pattern Arch Int Pharmacodyn Ther 92 97 107
68. LA Woodbury CA Swinyard 1952 Stimulus parameters for electroshock seizures in rats Am J Physiol 170 661 667